OncoMatch/Clinical Trials/NCT07729423
Mepitel Film Breast
Is NCT07729423 recruiting? Yes, currently enrolling (Sep 2026).
Primary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore Secondary Objectives To evaluate the incidence of acute radiation dermatitis, quality of life, satisfaction, and cost analysis of Mepitel Film use.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Demographics
Prior therapy
Cannot have received: radiation therapy
Prior RT to any portion of the planned treatment site.
Cannot have received: cytotoxic chemotherapy
Concomitant cytotoxic chemotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07729423 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiation therapy, cytotoxic chemotherapy disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 100 years or younger and at least 21 years old.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages